Navigation Links
Scientists Close in on Origins of Psoriasis, Eczema
Date:7/20/2011

By Maureen Salamon
HealthDay Reporter

WEDNESDAY, July 20 (HealthDay News) -- Psoriasis and eczema both cause red, scaly skin rashes, but the similarities between the two common, distressing conditions typically end there.

And now, examining patients suffering from both ailments (a very rare phenomenon), German scientists have teased out the opposing immune system responses that prompt skin flare-ups for both diseases.

They believe the findings could one day lead to more targeted, effective treatments.

The study, published in the July 21 issue of the New England Journal of Medicine, evaluated three patients with both psoriasis and eczema and noted that the T-cells -- types of white blood cells that fight infection -- found in psoriasis lesions differed from those found in eczema lesions.

The findings suggest that these T-cells migrate to the skin in response to distinct environmental triggers, not that the skin cells themselves are abnormal in either inflammatory condition, the study authors said.

"It's just another way for doctors to understand immune pathways and where they go awry," explained Dr. Doris Day, a dermatologist at Lenox Hill Hospital in New York City, who was not involved in the study. "It puts our understanding exponentially ahead and confuses us at the same time, because it's not supposed to happen [that patients can have both conditions]. The study definitely has value, and they're not making any claims or recommendations."

The most prevalent autoimmune disease in the United States, psoriasis affects up to 7.5 million Americans and is thought to arise from a combination of genetic and environmental triggers, according to the National Psoriasis Foundation. Eczema, on the other hand, is thought to be an allergic response and often occurs simultaneously in those with asthma or food allergies, according to the American Academy of Allergy, Asthma and Immunology. It is often outgrown by adulthood.

Psoriasis lesions in the study participants contained large numbers of so-called Th1 and Th17 cells, whereas eczema lesions had higher amounts of Th2 and Th22 cells. The researchers expanded their testing to include five patients with psoriasis and skin allergies to nickel -- a much more common combination that prompts an eczema-like reaction -- to confirm a similar T-cell response to psoriasis.

The study also found that all eczema lesions, but none in psoriasis, harbored Staphylococcus aureus bacteria, confirming that T-cells in psoriasis appear to prompt an innate immune response that's different from what is seen in eczema.

Dr. Jerry Bagel, a spokesman for the National Psoriasis Foundation and associate clinical professor of dermatology at Columbia University in New York City, said the research indicates that eczema and psoriasis "are clearly distinct entities, but there is some crossover immunologically."

If scientists could determine which antigens stimulate each condition -- a job that would likely take years -- they might find new ways to stop the disorders from developing in predisposed people, Bagel and Day agreed.

Current psoriasis treatments, which include both topical and systemic drugs, aim to suppress the body's immune response and slow down the skin cell growth cycle that leads to its trademark red, scaly plaques. Eczema treatments can involve both medications and lifestyle changes that cut itching, inflammation and worsening of the condition.

But, perhaps in the future, "they could have more direct testing to see if patients have an immune system alteration," Day said. "The more we understand the pathways and how the immune system responds to insults from the external world . . . we can adjust steps along the way, or medications that minimize side effects and maximize safety."

More information

Find out more about eczema and psoriasis at the International Eczema-Psoriasis Foundation.

SOURCES: Doris Day, M.D., dermatologist, Lenox Hill Hospital, New York City; Jerry Bagel, M.D., spokesman, National Psoriasis Foundation, director, Psoriasis Treatment Center of Central New Jersey, East Windsor, N.J., and associate clinical professor, dermatology, Columbia University, New York City; July 21, 2011, New England Journal of Medicine


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Scientists Pinpoint Area of Brain That Fears Losing Money
2. Scientists Discover How HIV Is Transmitted Between Men
3. Prevention Is Key Research Goal for Premature Babies, Scientists Say
4. Scientists Discover Molecular Pathway for Organ Tissue Regeneration and Repair
5. Scientists find donut-shaped structure of enzyme involved in energy metabolism
6. Neuroscientists reveal new links that regulate brain electrical activity
7. Two UCSF Scientists to Receive Prestigious Dementia Research Honor
8. Johns Hopkins scientists develop personalized blood tests for cancer using whole genome sequencing
9. Scientists Spot Genetic Fingerprints of Individual Cancers
10. Scientists Unravel Mysteries of Intelligence
11. MSU scientists develop more effective method of predicting lead-poisoning risk
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Scientists Close in on Origins of Psoriasis, Eczema 
(Date:2/24/2017)... ... 24, 2017 , ... The narrative in “ Signal 8: An Australian Paramedic’s ... of his paramedic experiences. Schanssema describes the tragedies he saw, as well as his ... them. , Schanssema, initially unsure of the career path he wanted to take, found ...
(Date:2/24/2017)... ... ... Indiana Fiber Network (IFN) President and CEO Kelly C. Dyer recently announced ... the Chairman of the Management Committee when IFN was originally formed in 2002 where ... investor/owners and development of the business plan. He became the first paid employee ...
(Date:2/23/2017)... ... February 23, 2017 , ... Thinksport, the most award-winning sunscreen ... Fondo of Marin. For the second year in a row, cyclists will stay ... “We are thrilled to provide our safe, non-toxic sunscreen to over 2,000 cycling ...
(Date:2/23/2017)... ... February 23, 2017 , ... The American Cleft Palate-Craniofacial Association (ACPA) is pleased ... KLS is a longtime supporter of the event. , "We are pleased that KLS ... Dr. Bob Havlik, 2017 ACPA President. "KLS Martin has a long track record of ...
(Date:2/23/2017)... California (PRWEB) , ... February 23, 2017 , ... ... Sports Development will host a diverse symposium on “Doping in Sport: ... Law and Sheppard Mullin Richter & Hampton LLP. The symposium will be held ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... Februar 2017 LG Innotek hat heute die ... Sterilisationsleistung beträgt das 1,5-fache des 45-mW-Moduls der Konkurrenz. ... zwischen 200 und 280 nm und eignet sich damit für ... ihre DNA zerstört. Das Produkt von LG Innotek erzeugt ... ...
(Date:2/23/2017)... 23, 2017 Nevro Corp. (NYSE: NVRO), a global ... the treatment of chronic pain, today reported financial results for ... 2016 Accomplishment & Highlights: ... an increase of 228% as reported, over the prior year ... increase of 612% over the prior year ...
(Date:2/23/2017)... Research and Markets has announced the addition ... 2016" report to their offering. ... The latest research Oesophageal Cancer Drugs Price ... in the global Oesophageal Cancer market. The research answers ... key drugs marketed for Oesophageal Cancer and their clinical attributes? How ...
Breaking Medicine Technology: